Impact of High Flow Therapy on Complications Related to Airway Stenting (HiSTENT)
Airway Obstruction, Respiratory Infection, Mucus; Plug
About this trial
This is an interventional treatment trial for Airway Obstruction focused on measuring high flow nasal cannula, airway stent, nebulized saline
Eligibility Criteria
Inclusion Criteria: Written informed consent Central Airway obstruction, both malignant and nonmalignant, treated with airway stenting (silicone or fully covered metallic stent) Exclusion Criteria: Contraindication to HFNC (recent - within 3 months - nose surgery or facial trauma) Lack of written informed consent Neuropsychiatric disorders Pregnancy
Sites / Locations
- Hospital Universitari Germans Trias i Pujol
- Hospital Universitari de Bellvitge
- Hospital general universitario Santa lucia Universidad de Murcia
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
High flow nasal cannula group
nebulized saline group
Treatment with High Flow Nasal Cannula minimum twenty (20) minutes three times a day (one [1] hour a day in total) and up to 10 hours a day in total, according to patient's preferences.
Treatment with nebulization of 4-8 cc of normal saline three times daily